![Max E. Link](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
B. Bal | M | 61 | 12 years | |
John Caloz | M | 72 | 17 years | |
Michael Tardugno | M | 73 | 17 years | |
Richard Danzig | M | 80 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 23 years |
Frederick Fritz | M | 73 | 13 years | |
Jeffrey White | M | 70 | 10 years | |
David Truetzel | M | 67 | 14 years | |
David O’Brien | M | 59 | 10 years | |
Khursheed Anwer | M | 64 | 10 years | |
Felix Kratz | M | - | 10 years | |
Sarah Marshall | F | - | 10 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Cooper | M | 65 | 15 years | |
David Hallal | M | 56 | 10 years | |
David Brennan | M | 70 | 7 years | |
Steven Kriegsman | M | 82 | 20 years | |
Joseph A. Madri | M | 80 | 22 years | |
Yim-Pan Cheung | M | 77 | 24 years | |
Eric Kenneth Olson | M | 60 | 7 years | |
Lawrence Olanoff | M | 72 | 1 years | |
David W. Keiser | M | 72 | 16 years | |
Jeffrey Church | M | 67 | 14 years | |
Mark Reynolds | M | 62 | 14 years | |
Spencer J. Volk | M | - | 4 years | |
Anthony P. Deasey | M | 74 | 7 years | |
Melvin Booth | M | 79 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 years |
Kevin J. Ontiveros | M | 63 | 3 years | |
Laurence Jay Korn | M | 74 |
Protein Design Labs, Inc.
![]() Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 16 years |
Louis J. Ignarro | M | 83 | 20 years | |
Curran Simpson | M | 62 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 9 years |
William A. Haseltine | M | 79 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
Jaisim Shah | M | 63 |
Protein Design Labs, Inc.
![]() Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 6 years |
John Leone | M | 77 | 9 years | |
Herbert H. McDade | M | 97 | 15 years | |
Verle D. Blaha | M | - | 1 years | |
Kory Wentworth | M | 45 | 9 years | |
Ty Lombardi | M | 51 | 2 years | |
H. Watkins | M | 71 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 years |
John Tattory | M | 58 | 12 years | |
Steven W. Zeiger | M | - | - | |
John C. King | M | 49 | 9 years | |
Jack Mollen | M | 73 | 7 years | |
Mark Day | M | 52 | 2 years | |
Alberto R. Martinez | M | 74 | 10 years | |
William Keller | M | 75 | 6 years | |
Ann Margaret Veneman | F | 75 | - | |
Gilles Gallant | M | - |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
Lisa Lejuwaan | F | - | - | |
Chad Lewis | M | - | - | |
Michael V. Greco | M | 53 | 11 years | |
Gordon G. Esplin | M | 56 | - | |
Bryan McEntire | M | 71 | - | |
Russell Clayton | M | 63 | - | |
Pok Yu Chow | M | 71 | 16 years | |
Mary Templeton | F | 78 | - | |
Klaus Jenny | M | 82 |
University of St. Gallen
| 5 years |
Ben R. Shappley | M | - | - | |
Christian Stambach | M | 54 |
Centerpulse AG
![]() Centerpulse AG Medical SpecialtiesHealth Technology Centerpulse AG was a medical technology group, which served the reconstructive joint, spinal and dental implant markets. Its subsidiaries developed, produced and distributed medical implants and biological materials for orthopedic, spinal and dental markets worldwide. The product array included artificial joints, dental implants, spinal implants and instrumentation. The company was headquartered in Zurich, Switzerland.
Sulzer Medica
| 1 years |
Henry Morgan | M | 103 | 24 years | |
Kevin L. Davis | M | 58 | - | |
William W. Freimuth | M | - |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
Reyn E. Gallacher | M | - | - | |
Stacey M. Ambrose | F | - | - | |
Joseph Rubinfeld | M | 91 | 14 years | |
Scott Peters | M | - | 8 years | |
Gregory R. Liberman | M | 51 | - | |
Barry A. Labinger | M | 60 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 years |
Kathleen A. McGowan | F | 63 | 4 years | |
Thomas Miller | M | 52 | 11 years | |
W. Amick | M | 81 | 9 years | |
Benjamin S. Levin | M | 46 | 12 years | |
Larry L. Mathis | M | 80 | 10 years | |
Marvin R. Selter | M | 95 | 11 years | |
Joseph M. Mahady | M | 71 | 8 years | |
Richard L. Wennekamp | M | 80 | - | |
Augustine Lawlor | M | 67 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 years |
Richard Fritschi | M | 64 |
Sulzer Medica
| 4 years |
Robert C. Young | M | 84 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 years |
Christopher Coughlin | M | 71 | 7 years | |
Evan Myrianthopoulos | M | 59 | 9 years | |
Bradley G. Lorimier | M | 78 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 years |
Rockford Norby | M | 89 | 18 years | |
George T. Jue | M | 71 |
Protein Design Labs, Inc.
![]() Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 1 years |
Jürgen Drews | M | 91 |
Protein Design Labs, Inc.
![]() Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 13 years |
Douglas O. Ebersole | M | 68 |
Protein Design Labs, Inc.
![]() Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 14 years |
James H. Davis | M | 72 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 15 years |
Jay Moyes | M | 70 | 2 years | |
Alvin S. Parven | M | 83 | 19 years | |
Marvin E. Rosenthale | M | 90 | 20 years | |
M. Burns | F | 66 | 4 years | |
Robert Hooper | M | 77 | 12 years | |
Daniel J. Levitt | M | 76 | 8 years | |
Andreas Rummelt | M | 67 | 11 years | |
Tuan Ha-Ngoc | M | 72 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
Bruce Peacock | M | 72 | 11 years | |
Argeris Karabelas | M | 71 |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 11 years |
David Lopez | M | 65 | 11 years | |
Nicholas Borys | M | 64 | 16 years | |
Camille Bedrosian | M | 71 | 10 years | |
Niccolò Herbert Burki | M | 74 |
University of St. Gallen
| 4 years |
Johannes Attems | M | 76 |
University of St. Gallen
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 95 | 95.00% |
Switzerland | 5 | 5.00% |
United Kingdom | 0 | -.--% |
Germany | 0 | -.--% |
Canada | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Max E. Link
- Personal Network